speb/financial-data huggingface dataset:
Financial ratios for UKW.L — annual report dated 2023-12-31
Total revenue: 180696202.53164557
Net income: 159731645.56962025
Capital expenditures: 0
Operating cash flow: 455444303.7974683
Net tangible assets: 4802527848.101266
Owner earnings: 159731645.56962025
Return on net tangible assets (%): 3.3259910326760935
Buffett classification: The Gruesome
Stock price: 0.015316455696202531
P/E ratio: 0.20698696111278408
Shares outstanding: 2158617409
Book value: 4802527848.101265
P/B ratio: 0.006884367765419953
Market cap (USD): 33062367.91
Debt to equity: 0.47179794817971654
Effective tax rate (%): 0.3096855743403381
COGS to revenue (%): 0
SG&A to revenue (%): 5.296672504378284
Free cash flow (dilution-adjusted): 455444303.7974683
Buyback yield (%): 36.13806881088205
Retained earnings: 1644677215.1898735
Receivables turnover: 780.0546448087432
Capitalized R&D asset: 0
FCF margin (%): 252.0497373029772
Revenue growth (%): 207.05094305184852
Rule of 40 score: 459.1006803548257
Financial ratios for UKW.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4261380000
Buffett classification: The Gruesome
Stock price: 0.01375
Shares outstanding: 2158617409
Book value: 4261380000
P/B ratio: 0.006965112093676227
Market cap (USD): 29680989.37375
Debt to equity: 0.5162646842102793
Buyback yield (%): 0
Retained earnings: 1234085000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UKW.L — annual report dated 2024-12-31
Total revenue: -42043750
Net income: -69268750
Capital expenditures: 0
Operating cash flow: 488763750
Net tangible assets: 4261380000
Owner earnings: -69268750
Return on net tangible assets (%): -1.6255004247450355
Buffett classification: The Gruesome
Stock price: 0.01375
Shares outstanding: 2158617409
Book value: 4261380000
P/B ratio: 0.006965112093676227
Market cap (USD): 29680989.37375
Debt to equity: 0.5162646842102793
Free cash flow (dilution-adjusted): 488763750
Buyback yield (%): 338.6721673398847
Retained earnings: 1234085000
Receivables turnover: -8.791165708311553
Capitalized R&D asset: 0
Revenue growth (%): -123.26764448336252
Rule of 40 score: -123.26764448336252
Financial ratios for UKW.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 4359797260.2739725
Buffett classification: The Gruesome
Stock price: 0.014931506849315069
Shares outstanding: 2158617409
Book value: 4359797260.2739725
P/B ratio: 0.007392869141238188
Market cap (USD): 32231410.627534248
Debt to equity: 0.5529979400826732
Buyback yield (%): 0
Retained earnings: 1097158904.109589
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VEE.DE — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 223.55555555555554
Shares outstanding: 162443291
Market cap (USD): 36315100165.77778
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VEE.DE — annual report dated 2023-01-31
Total revenue: 2155060000
Gross profit: 1545655000
Operating income: 459091000
Net income: 487706000
Capital expenditures: 0
Operating cash flow: 780470000
Depreciation & amortization: 29122000
Net tangible assets: 3193899000
Owner earnings: 516828000
Return on net tangible assets (%): 16.181726472878445
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 170.6086956521739
P/E ratio: 56.82570646036038
Shares outstanding: 162443291
Book value: 3716252000
P/B ratio: 7.4575776871311525
Market cap (USD): 27714237994.95652
Debt to equity: 0.01640792927928461
Current ratio: 3.942492225390667
Quick ratio: 3.942492225390667
Effective tax rate (%): 4.201565127205871
COGS to revenue (%): 28.27786697354134
R&D to revenue (%): 24.14215845498501
SG&A to revenue (%): 26.277041010459108
Free cash flow (dilution-adjusted): 428563000
Buyback yield (%): 0
Retained earnings: 2214752000
Receivables turnover: 2.7444987385845403
Capitalized R&D asset: 520278000
ROCI (R&D-adjusted, %): 18.665718955451784
FCF margin (%): 19.88636047256225
Rule of 40 score: 19.88636047256225
Financial ratios for VEE.DE — annual report dated 2024-01-31
Total revenue: 2363673000
Gross profit: 1686382000
Operating income: 429334000
Net income: 525705000
Capital expenditures: 0
Operating cash flow: 911339000
Depreciation & amortization: 32628000
Net tangible assets: 4141930000
Owner earnings: 558333000
Return on net tangible assets (%): 13.480020183827346
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 211.35869565217388
P/E ratio: 65.31001626997369
Shares outstanding: 162443291
Book value: 4644824000
P/B ratio: 7.391841349253817
Market cap (USD): 34333802103.206516
Debt to equity: 0.012007989969049419
Current ratio: 4.244026760925385
Quick ratio: 4.244026760925385
Effective tax rate (%): 10.59788477661588
COGS to revenue (%): 28.65417509105532
R&D to revenue (%): 26.61243750721864
SG&A to revenue (%): 26.56953817215833
Free cash flow (dilution-adjusted): 517606000
Buyback yield (%): 0
Retained earnings: 2740457000
Receivables turnover: 2.660185225826274
Capitalized R&D asset: 977617260
ROCI (R&D-adjusted, %): 11.826670569716773
Rosenberg metric: 0.27048424111724884
FCF margin (%): 21.89837595978801
Revenue growth (%): 9.680148116525759
Rule of 40 score: 31.57852407631377
Financial ratios for VEE.DE — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 210.43478260869563
Shares outstanding: 162443291
Market cap (USD): 34183718627.826084
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VEE.DE — quarterly report dated 2025-01-31
Total revenue: 720886000
Gross profit: 539895000
Operating income: 188423000
Net income: 195625000
Capital expenditures: 0
Operating cash flow: 69544000
Depreciation & amortization: 9932000
Net tangible assets: 5348036000
Owner earnings: 205557000
Return on net tangible assets (%): 3.8435979114575893
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 237.60416666666666
P/E ratio: 49.32549877143238
Shares outstanding: 162443291
Book value: 5832373000
P/B ratio: 6.617752806387012
Market cap (USD): 38597202788.64583
Debt to equity: 0.012992138877263165
Current ratio: 4.511430173254653
Quick ratio: 4.511430173254653
Effective tax rate (%): 20.195406518989923
COGS to revenue (%): 25.10674364601338
R&D to revenue (%): 25.181096595023345
SG&A to revenue (%): 23.574462536378846
Free cash flow (dilution-adjusted): -45660000
Buyback yield (%): 0
Retained earnings: 3454595000
Receivables turnover: 0.6819358689719303
Capitalized R&D asset: 181527000
ROCI (R&D-adjusted, %): 5.053848034560213
FCF margin (%): -6.3338724846924475
Rule of 40 score: -6.3338724846924475
Financial ratios for VEE.DE — annual report dated 2025-01-31
Total revenue: 2746619000
Gross profit: 2046983000
Operating income: 691435000
Net income: 714138000
Capital expenditures: 0
Operating cash flow: 1090051000
Depreciation & amortization: 39383000
Net tangible assets: 5348036000
Owner earnings: 753521000
Return on net tangible assets (%): 14.08967703283972
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 237.60416666666666
P/E ratio: 54.04726087765366
Shares outstanding: 162443291
Book value: 5832373000
P/B ratio: 6.617752806387012
Market cap (USD): 38597202788.64583
Debt to equity: 0.012992138877263165
Current ratio: 4.511430173254653
Quick ratio: 4.511430173254653
Effective tax rate (%): 22.3240419369119
COGS to revenue (%): 25.47262652737784
R&D to revenue (%): 25.233860247817407
SG&A to revenue (%): 24.119471976273374
Free cash flow (dilution-adjusted): 652701000
Buyback yield (%): 0
Retained earnings: 3454595000
Receivables turnover: 2.598216659083148
Capitalized R&D asset: 1286220510
ROCI (R&D-adjusted, %): 10.658959130940632
Rosenberg metric: 0.5732642747336777
FCF margin (%): 23.76379832805351
Revenue growth (%): 16.201310418150058
Rule of 40 score: 39.96510874620357
Financial ratios for VEE.DE — quarterly report dated 2025-04-30
Total revenue: 759043000
Gross profit: 585219000
Operating income: 233732000
Net income: 228190000
Capital expenditures: 0
Operating cash flow: 877158000
Depreciation & amortization: 9822000
Net tangible assets: 5730702000
Owner earnings: 238012000
Return on net tangible assets (%): 4.153278254566369
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 211.59090909090907
P/E ratio: 37.65669356502157
Shares outstanding: 162443291
Book value: 6211098000
P/B ratio: 5.533888471637234
Market cap (USD): 34371523618.40909
Debt to equity: 0.012434355407047192
Current ratio: 4.604884070099608
Quick ratio: 4.604884070099608
Effective tax rate (%): 23.636558340946586
COGS to revenue (%): 22.900415391486383
R&D to revenue (%): 24.24539848203593
SG&A to revenue (%): 22.06120074883768
Free cash flow (dilution-adjusted): 764948000
Buyback yield (%): 0
Retained earnings: 3682785000
Receivables turnover: 1.4023163697767136
Capitalized R&D asset: 305656090
ROCI (R&D-adjusted, %): 4.4739385230404345
Rosenberg metric: 0.24968186550761043
FCF margin (%): 100.77795329118378
Revenue growth (%): 5.293069916741343
Rule of 40 score: 106.07102320792512
Financial ratios for VEE.DE — quarterly report dated 2025-07-31
Total revenue: 789081000
Gross profit: 593828000
Operating income: 195908000
Net income: 200309000
Capital expenditures: 0
Operating cash flow: 238433000
Depreciation & amortization: 10126000
Net tangible assets: 6162217000
Owner earnings: 210435000
Return on net tangible assets (%): 3.414923557544306
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 211.59090909090907
P/E ratio: 55.07162618070942
Shares outstanding: 162443291
Book value: 6638539000
P/B ratio: 5.177573502002336
Market cap (USD): 34371523618.40909
Debt to equity: 0.012871506817991128
Current ratio: 5.573141532668341
Quick ratio: 5.573141532668341
Effective tax rate (%): 24.515382644217002
COGS to revenue (%): 24.744354508599244
R&D to revenue (%): 24.41789879619456
SG&A to revenue (%): 26.010384231783558
Free cash flow (dilution-adjusted): 116467000
Buyback yield (%): 0
Retained earnings: 3883094000
Receivables turnover: 1.6702990353901939
Capitalized R&D asset: 375883020
ROCI (R&D-adjusted, %): 2.844082726665392
Rosenberg metric: 0.046779653649073806
FCF margin (%): 14.75982820521594
Revenue growth (%): 3.957351559793055
Rule of 40 score: 18.717179765008996
Financial ratios for VEE.DE — quarterly report dated 2025-10-31
Total revenue: 811236000
Gross profit: 611771000
Operating income: 240853000
Net income: 236203000
Capital expenditures: 0
Operating cash flow: 192787000
Depreciation & amortization: 9706000
Net tangible assets: 6568104000
Owner earnings: 245909000
Return on net tangible assets (%): 3.7439876104276055
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 265.75581395348837
P/E ratio: 50.17888433233919
Shares outstanding: 162443291
Book value: 7040631000
P/B ratio: 6.131588066607719
Market cap (USD): 43170249020.98837
Debt to equity: 0.012753970489292792
Current ratio: 7.526743135092572
Quick ratio: 7.526743135092572
Effective tax rate (%): 24.484152103994425
COGS to revenue (%): 24.587789496521356
R&D to revenue (%): 23.653166279602978
SG&A to revenue (%): 22.069410134658717
Free cash flow (dilution-adjusted): 72519000
Buyback yield (%): 0
Retained earnings: 4119297000
Receivables turnover: 2.182055861594078
Capitalized R&D asset: 381707480
ROCI (R&D-adjusted, %): 3.228107647021671
Rosenberg metric: 0.09312476320474161
FCF margin (%): 8.939322219428131
Revenue growth (%): 2.807696548263106
Rule of 40 score: 11.747018767691237
Financial ratios for VEE.DE — quarterly report dated 2026-01-31
Total revenue: 835951000
Gross profit: 622474000
Operating income: 245876000
Net income: 244204000
Capital expenditures: 0
Operating cash flow: 106847000
Depreciation & amortization: 8318000
Net tangible assets: 6744561000
Owner earnings: 252522000
Return on net tangible assets (%): 3.7440835660022946
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 208.1547619047619
P/E ratio: 37.2022459540711
Shares outstanding: 162443291
Book value: 7214752000
P/B ratio: 4.686695337709591
Market cap (USD): 33813344561.13095
Debt to equity: 0.013286527381675767
Current ratio: 4.885373499745885
Quick ratio: 4.885373499745885
Effective tax rate (%): 23.09431656783304
COGS to revenue (%): 25.537023103028766
R&D to revenue (%): 23.780460816483263
SG&A to revenue (%): 21.26978734399504
Free cash flow (dilution-adjusted): -11412000
Buyback yield (%): 0
Retained earnings: 4363501000
Receivables turnover: 0.6379620344550218
Capitalized R&D asset: 390938020
ROCI (R&D-adjusted, %): 3.2356229044528693
Rosenberg metric: 0.05577878186186374
FCF margin (%): -1.3651517852122912
Revenue growth (%): 3.0465857037902655
Rule of 40 score: 1.6814339185779743
Financial ratios for VEE.DE — annual report dated 2026-01-31
Total revenue: 3195311000
Gross profit: 2413292000
Operating income: 916369000
Net income: 908906000
Capital expenditures: 0
Operating cash flow: 1415225000
Depreciation & amortization: 37972000
Net tangible assets: 6744561000
Owner earnings: 946878000
Return on net tangible assets (%): 14.039134644938345
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 208.1547619047619
P/E ratio: 37.2022459540711
Shares outstanding: 162443291
Book value: 7214752000
P/B ratio: 4.686695337709591
Market cap (USD): 33813344561.13095
Debt to equity: 0.013286527381675767
Current ratio: 4.885373499745885
Quick ratio: 4.885373499745885
Effective tax rate (%): 23.909592903521784
COGS to revenue (%): 24.473955743275067
R&D to revenue (%): 24.016003450055408
SG&A to revenue (%): 22.831486512580465
Free cash flow (dilution-adjusted): 942522000
Buyback yield (%): 0.5026092573976235
Retained earnings: 4363501000
Receivables turnover: 2.4385246339516433
Capitalized R&D asset: 1439328490
ROCI (R&D-adjusted, %): 11.242312622215103
Rosenberg metric: 0.5285249279301897
FCF margin (%): 29.49703487391368
Revenue growth (%): 16.33615729010831
Rule of 40 score: 45.833192164021995
Financial ratios for VOW.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 195.23863636363637
Shares outstanding: 295089818
Market cap (USD): 57612933671.11364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VOW.DE — annual report dated 2022-12-31
Total revenue: 296861702127.6596
Gross profit: 55514893617.02128
Operating income: 19668085106.38298
Net income: 16863829787.234043
Capital expenditures: 24118085106.38298
Operating cash flow: 30314893617.02128
Depreciation & amortization: 30303191489.361702
Net tangible assets: 87377659574.4681
Owner earnings: 23048936170.21277
Return on net tangible assets (%): 26.378523163085166
Capex to operating income (%): 122.62548680225012
Buffett classification: The Gruesome
Stock price: 122.25531914893618
P/E ratio: 2.1392708733636137
Shares outstanding: 295089818
Book value: 189710638297.87238
P/B ratio: 0.1901648753115607
Market cap (USD): 36076299877.19149
Debt to equity: 1.0006056255888025
Current ratio: 1.2267694816744472
Quick ratio: 0.9470619462246133
Effective tax rate (%): 28.169460806524693
Interest coverage ratio: 11.245742092457421
COGS to revenue (%): 81.29940870811681
SG&A to revenue (%): 11.286507794302096
Free cash flow (dilution-adjusted): 6196808510.638298
Buyback yield (%): 0
Retained earnings: 146034042553.1915
Inventory turnover: 4.438865953158935
Receivables turnover: 4.6352280655127736
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.8488027485640846
FCF margin (%): 2.0874395269664934
Rule of 40 score: 2.0874395269664934
Financial ratios for VOW.DE — annual report dated 2023-12-31
Total revenue: 358093333333.3333
Gross profit: 67761111111.11111
Operating income: 28554444444.444443
Net income: 19845555555.555553
Capital expenditures: 28661111111.11111
Operating cash flow: 21506666666.666668
Depreciation & amortization: 30628888888.88889
Net tangible assets: 95398888888.88889
Owner earnings: 21813333333.333332
Return on net tangible assets (%): 22.8653955904448
Capex to operating income (%): 100.37355539126037
Buffett classification: The Gruesome
Stock price: 108.56666666666666
P/E ratio: 1.614311971153911
Shares outstanding: 295089818
Book value: 210206666666.66663
P/B ratio: 0.15240676433129302
Market cap (USD): 32036917907.533333
Debt to equity: 1.0252978550209848
Current ratio: 1.163117125162593
Quick ratio: 0.9109621619522802
Effective tax rate (%): 22.671977141867615
Interest coverage ratio: 7.060164835164835
COGS to revenue (%): 81.07724863784736
SG&A to revenue (%): 10.572662620545854
Free cash flow (dilution-adjusted): -7154444444.444445
Buyback yield (%): 0
Retained earnings: 163448888888.8889
Inventory turnover: 5.029526687583008
Receivables turnover: 4.795678764340877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.512456508021784
FCF margin (%): -1.9979272939395067
Revenue growth (%): 20.626315475123914
Rule of 40 score: 18.628388181184405
Financial ratios for VOW.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 98.28888888888888
Shares outstanding: 295089818
Market cap (USD): 29004050333.64444
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VOW.DE — annual report dated 2024-12-31
Total revenue: 338182291666.6667
Gross profit: 61948958333.333336
Operating income: 22566666666.666668
Net income: 12910416666.666668
Capital expenditures: 28589583333.333336
Operating cash flow: 17865625000
Depreciation & amortization: 32652083333.333336
Net tangible assets: 92667708333.33334
Owner earnings: 16972916666.666664
Return on net tangible assets (%): 18.315891233237032
Capex to operating income (%): 126.6894387001477
Buffett classification: The Gruesome
Stock price: 84.66666666666667
P/E ratio: 1.935202550188801
Shares outstanding: 295089818
Book value: 204928125000.00006
P/B ratio: 0.12191723931175054
Market cap (USD): 24984271257.333336
Debt to equity: 0.9989274694887941
Current ratio: 1.1298937057395213
Quick ratio: 0.8850897764917826
Effective tax rate (%): 26.24657860287993
Interest coverage ratio: 6.284885407600813
COGS to revenue (%): 81.68178527975853
SG&A to revenue (%): 10.8034682971154
Free cash flow (dilution-adjusted): -10723958333.333334
Buyback yield (%): 0
Retained earnings: 161593750000
Inventory turnover: 4.9910411804562225
Receivables turnover: 4.796415855334112
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.209370326018477
FCF margin (%): -3.171058508262617
Revenue growth (%): -5.560293871243985
Rule of 40 score: -8.731352379506601
Financial ratios for VOW.DE — quarterly report dated 2024-12-31
Total revenue: 91018750000
Gross profit: 17800000000
Operating income: 9123958333.333334
Net income: 3621875000
Capital expenditures: 10506250000
Operating cash flow: 5546875000
Depreciation & amortization: 8972916666.666668
Net tangible assets: 92667708333.33334
Owner earnings: 2088541666.666668
Return on net tangible assets (%): 2.2537966075021654
Capex to operating income (%): 115.15013129352664
Buffett classification: The Gruesome
Stock price: 84.66666666666667
P/E ratio: 1.7245398624561403
Shares outstanding: 295089818
Book value: 204928125000.00006
P/B ratio: 0.12191723931175054
Market cap (USD): 24984271257.333336
Debt to equity: 0.9989274694887941
Current ratio: 1.1298937057395213
Quick ratio: 0.8850897764917826
Effective tax rate (%): 18.771888862946533
COGS to revenue (%): 80.4435899196594
SG&A to revenue (%): 11.101192519856259
Free cash flow (dilution-adjusted): -4959375000
Buyback yield (%): 0
Retained earnings: 161593750000
Inventory turnover: 1.3229315666641572
Receivables turnover: 1.2909125829184334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1062072879244753
FCF margin (%): -5.448739957426355
Rule of 40 score: -5.448739957426355
Financial ratios for VOW.DE — quarterly report dated 2025-03-31
Total revenue: 84303260869.56522
Gross profit: 13914130434.782608
Operating income: 3125000000
Net income: 2376086956.521739
Capital expenditures: 5530434782.608695
Operating cash flow: 3234782608.695652
Depreciation & amortization: 8476086956.521739
Net tangible assets: 99495652173.91304
Owner earnings: 5321739130.434783
Return on net tangible assets (%): 5.348715259570006
Capex to operating income (%): 176.97391304347826
Buffett classification: The Gruesome
Stock price: 91.83695652173913
P/E ratio: 2.8513424888860937
Shares outstanding: 295089818
Book value: 218626086956.52173
P/B ratio: 0.12395662001242941
Market cap (USD): 27100150785.673912
Debt to equity: 0.9465684909712831
Current ratio: 1.0959180082695523
Quick ratio: 0.8438154306325328
Effective tax rate (%): 29.688002573174654
COGS to revenue (%): 83.49514563106796
SG&A to revenue (%): 11.306231385139055
Free cash flow (dilution-adjusted): -2295652173.9130435
Buyback yield (%): 0
Retained earnings: 172144565217.3913
Inventory turnover: 1.1299007206044005
Receivables turnover: 0.8480656942287926
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6977647258694756
FCF margin (%): -2.7230882296058483
Revenue growth (%): -7.378138164317555
Rule of 40 score: -10.101226393923403
Financial ratios for VOW.DE — quarterly report dated 2025-06-30
Total revenue: 95065882352.94118
Gross profit: 16002352941.176472
Operating income: 4511764705.882353
Net income: 2747058823.529412
Capital expenditures: 6738823529.411765
Operating cash flow: 398823529.41176474
Depreciation & amortization: 9762352941.176472
Net tangible assets: 104522352941.17647
Owner earnings: 5770588235.294118
Return on net tangible assets (%): 5.520913061095854
Capex to operating income (%): 149.36114732724903
Buffett classification: The Gruesome
Stock price: 101.32941176470588
P/E ratio: 3.419234605354388
Shares outstanding: 295089818
Book value: 232962352941.1765
P/B ratio: 0.12835240242977908
Market cap (USD): 29901277675.69412
Debt to equity: 0.9501459463281114
Current ratio: 1.0921363630406005
Quick ratio: 0.8356059050456772
Effective tax rate (%): 30.86904043452022
COGS to revenue (%): 83.16709155260749
SG&A to revenue (%): 10.79746553473752
Free cash flow (dilution-adjusted): -6340000000
Buyback yield (%): 0
Retained earnings: 186040000000
Inventory turnover: 1.1445407633223768
Receivables turnover: 0.8874416561418922
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.938123020095647
FCF margin (%): -6.6690592282751275
Revenue growth (%): 12.766554190623763
Rule of 40 score: 6.097494962348636
Financial ratios for VOW.DE — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 103.58823529411765
P/E ratio: 3.495455787779564
Shares outstanding: 295089818
Market cap (USD): 30567833499.882355
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VOW.DE — annual report dated 2025-12-31
Total revenue: 378721176470.58826
Gross profit: 60284705882.35294
Operating income: 12698823529.411764
Net income: 8615294117.647058
Capital expenditures: 28642352941.17647
Operating cash flow: 17657647058.82353
Depreciation & amortization: 44040000000
Net tangible assets: 113885882352.94118
Owner earnings: 24012941176.470585
Return on net tangible assets (%): 21.085090338109353
Capex to operating income (%): 225.55123216601817
Buffett classification: The Gruesome
Stock price: 116.12941176470588
P/E ratio: 3.977647949580773
Shares outstanding: 295089818
Book value: 238887058823.52948
P/B ratio: 0.1434510816569976
Market cap (USD): 34268606982.094116
Debt to equity: 0.9670186255872819
Current ratio: 1.0942059375344884
Quick ratio: 0.8656439686568811
Effective tax rate (%): 25.819275813903513
Interest coverage ratio: 3.327373612823674
COGS to revenue (%): 84.08203458698468
SG&A to revenue (%): 10.979674632587063
Free cash flow (dilution-adjusted): -10984705882.352942
Buyback yield (%): 0
Retained earnings: 189831764705.88235
Inventory turnover: 5.227831965234186
Receivables turnover: 4.83875962000962
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.582655009546779
FCF margin (%): -2.900473109194099
Revenue growth (%): 11.987287863043756
Rule of 40 score: 9.086814753849657
Financial ratios for VOW.DE — quarterly report dated 2025-12-31
Total revenue: 97935294117.64706
Gross profit: 17170588235.294119
Operating income: 5277647058.823529
Net income: 4116470588.2352943
Capital expenditures: 9614117647.058825
Operating cash flow: 5810588235.294118
Depreciation & amortization: 11378823529.411764
Net tangible assets: 113885882352.94118
Owner earnings: 5881176470.588234
Return on net tangible assets (%): 5.164096154044811
Capex to operating income (%): 182.16674097191265
Buffett classification: The Gruesome
Stock price: 116.12941176470588
P/E ratio: 3.7088776867095707
Shares outstanding: 295089818
Book value: 238887058823.52948
P/B ratio: 0.1434510816569976
Market cap (USD): 34268606982.094116
Debt to equity: 0.9670186255872819
Current ratio: 1.0942059375344884
Quick ratio: 0.8656439686568811
Effective tax rate (%): -7.727832512315272
COGS to revenue (%): 82.46741546038801
SG&A to revenue (%): 11.308787314553426
Free cash flow (dilution-adjusted): -3803529411.764706
Buyback yield (%): 0
Retained earnings: 189831764705.88235
Inventory turnover: 1.3259295026557218
Receivables turnover: 1.2512776575276576
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0733546760076755
FCF margin (%): -3.883716739744129
Rule of 40 score: -3.883716739744129
Financial ratios for WCAT.L — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.00041666666666666664
Shares outstanding: 3004470000
Market cap (USD): 1251862.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WCAT.L — annual report dated 2022-06-30
Total revenue: 0
Operating income: -372858.5365853659
Net income: -372858.5365853659
Capital expenditures: 0
Operating cash flow: -249828.04878048782
Net tangible assets: 131709.75609756098
Owner earnings: -372858.5365853659
Return on net tangible assets (%): -283.0910538693728
Buffett classification: The Gruesome
Stock price: 0.00012195121951219514
Shares outstanding: 3004470000
Book value: 131709.75609756098
P/B ratio: 2.7818651506453587
Market cap (USD): 366398.7804878049
Debt to equity: 0
Current ratio: 2.50636707254139
Quick ratio: 2.50636707254139
Free cash flow (dilution-adjusted): -258974.39024390245
Buyback yield (%): 0
Retained earnings: -933402.4390243903
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -283.0910538693728
Rule of 40 score: 0
Financial ratios for WCAT.L — annual report dated 2023-06-30
Total revenue: 0
Operating income: -331641.7721518987
Net income: -331641.7721518987
Capital expenditures: 0
Operating cash flow: -354311.39240506326
Net tangible assets: 136677.21518987342
Owner earnings: -331641.7721518987
Return on net tangible assets (%): -242.64598286640427
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3004470000
Book value: 136677.21518987342
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 3.371617466174662
Quick ratio: 3.371617466174662
Free cash flow (dilution-adjusted): -354311.39240506326
Retained earnings: -1300489.8734177214
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -242.64598286640427
Rule of 40 score: 0
Financial ratios for WCAT.L — annual report dated 2024-06-30
Total revenue: 0
Operating income: -323149.36708860757
Net income: -323149.36708860757
Capital expenditures: 0
Operating cash flow: -307521.5189873418
Net tangible assets: 320501.2658227848
Owner earnings: -323149.36708860757
Return on net tangible assets (%): -100.82623738131724
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3004470000
Book value: 320501.2658227848
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 7.778827876094348
Quick ratio: 7.778827876094348
Free cash flow (dilution-adjusted): -316077.2151898734
Retained earnings: -1299545.569620253
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -100.82623738131724
Rule of 40 score: 0
Financial ratios for WCAT.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 310000
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3004470000
Book value: 310000
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 8.085714285714285
Quick ratio: 8.085714285714285
Retained earnings: -1476250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WCAT.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 198769.86301369863
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3004470000
Book value: 198769.86301369863
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 3.4140615901642075
Quick ratio: 3.4140615901642075
Retained earnings: -1831506.8493150685
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WCAT.L — annual report dated 2025-06-30
Total revenue: 0
Operating income: -425149.3150684932
Net income: -425149.3150684932
Capital expenditures: 0
Operating cash flow: -329927.397260274
Net tangible assets: 198769.86301369863
Owner earnings: -425149.3150684932
Return on net tangible assets (%): -213.89022894239918
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3004470000
Book value: 198769.86301369863
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 3.4140615901642075
Quick ratio: 3.4140615901642075
Free cash flow (dilution-adjusted): -408263.01369863015
Retained earnings: -1831506.8493150685
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -213.89022894239918
Rule of 40 score: 0
Financial ratios for XRAY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 50.33
Shares outstanding: 200326683
Market cap (USD): 10082441955.39
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XRAY — annual report dated 2022-12-31
Total revenue: 3922000000
Gross profit: 2127000000
Operating income: 364000000
Net income: -950000000
Capital expenditures: 0
Operating cash flow: 517000000
Depreciation & amortization: 328000000
Net tangible assets: -780000000
Owner earnings: -622000000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 29.14
Shares outstanding: 200326683
Book value: 3812000000
P/B ratio: 1.5313535001626444
Market cap (USD): 5837519542.62
Debt to equity: 0.5632214060860441
Current ratio: 1.617948717948718
Quick ratio: 1.082051282051282
Interest coverage ratio: 5.6
COGS to revenue (%): 45.76746557878633
R&D to revenue (%): 4.436511983681795
SG&A to revenue (%): 40.69352371239164
Free cash flow (dilution-adjusted): 309000000
Buyback yield (%): 2.5695845453679955
Retained earnings: 456000000
Inventory turnover: 2.8628389154704945
Receivables turnover: 5.725547445255475
Capitalized R&D asset: 174000000
ROCI (R&D-adjusted, %): 7.221302843387995
FCF margin (%): 7.878633350331464
Rule of 40 score: 7.878633350331464
Financial ratios for XRAY — annual report dated 2023-12-31
Total revenue: 3965000000
Gross profit: 2086000000
Operating income: 289000000
Net income: -132000000
Capital expenditures: 7000000
Operating cash flow: 377000000
Depreciation & amortization: 343000000
Net tangible assets: -850000000
Owner earnings: 204000000
Capex to operating income (%): 2.422145328719723
Buffett classification: The Great
Stock price: 33.07
Shares outstanding: 200326683
Book value: 3294000000
P/B ratio: 2.011172861812386
Market cap (USD): 6624803406.81
Debt to equity: 0.6979356405585914
Current ratio: 1.3845614035087719
Quick ratio: 0.9466666666666667
Interest coverage ratio: 3.567901234567901
COGS to revenue (%): 47.38965952080706
R&D to revenue (%): 4.640605296343002
SG&A to revenue (%): 40.85750315258512
Free cash flow (dilution-adjusted): 182000000
Buyback yield (%): 4.528436265619798
Retained earnings: 205000000
Inventory turnover: 3.011217948717949
Receivables turnover: 5.244708994708994
Capitalized R&D asset: 300580000
ROCI (R&D-adjusted, %): 5.662671307815554
Rosenberg metric: -0.23563218390804597
FCF margin (%): 4.590163934426229
Revenue growth (%): 1.0963793982661907
Rule of 40 score: 5.68654333269242
Financial ratios for XRAY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.58
Shares outstanding: 200326683
Market cap (USD): 5124356551.139999
Buyback yield (%): 1.9514645205114252
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XRAY — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.1
Shares outstanding: 200326683
Market cap (USD): 3625912962.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XRAY — annual report dated 2024-12-31
Total revenue: 3793000000
Gross profit: 1958000000
Operating income: 188000000
Net income: -910000000
Capital expenditures: 180000000
Operating cash flow: 461000000
Depreciation & amortization: 349000000
Net tangible assets: -862000000
Owner earnings: -741000000
Capex to operating income (%): 95.74468085106383
Buffett classification: The Gruesome
Stock price: 18.1
Shares outstanding: 200326683
Book value: 1943000000
P/B ratio: 1.8661415143077715
Market cap (USD): 3625912962.3
Debt to equity: 1.1693257848687597
Current ratio: 1.0988042794210195
Quick ratio: 0.7438640654499685
Interest coverage ratio: 2.7246376811594204
COGS to revenue (%): 48.3785921434221
R&D to revenue (%): 4.350118639599262
SG&A to revenue (%): 42.31479040337464
Free cash flow (dilution-adjusted): 242000000
Buyback yield (%): 6.894815253409151
Retained earnings: -835000000
Inventory turnover: 3.25354609929078
Receivables turnover: 6.259075907590759
Capitalized R&D asset: 345700000
ROCI (R&D-adjusted, %): 3.9618304247880496
Rosenberg metric: -0.6956521739130435
FCF margin (%): 6.380174004745584
Revenue growth (%): -4.337957124842371
Rule of 40 score: 2.0422168799032123
Financial ratios for XRAY — quarterly report dated 2025-03-31
Total revenue: 879000000
Gross profit: 466000000
Operating income: 70000000
Net income: 20000000
Capital expenditures: 1000000
Operating cash flow: 7000000
Depreciation & amortization: 79000000
Net tangible assets: -834000000
Owner earnings: 98000000
Return on net tangible assets (%): -11.750599520383693
Capex to operating income (%): 1.4285714285714286
Buffett classification: The Great
Stock price: 14.39
P/E ratio: 36.033762104625005
Shares outstanding: 200326683
Book value: 2010000000
P/B ratio: 1.4341795862537314
Market cap (USD): 2882700968.37
Debt to equity: 1.2054726368159203
Current ratio: 1.1031790295593977
Quick ratio: 0.7618516452872282
Effective tax rate (%): 56.81818181818182
Interest coverage ratio: 3.6842105263157894
COGS to revenue (%): 46.985210466439135
R&D to revenue (%): 4.09556313993174
SG&A to revenue (%): 40.955631399317404
Free cash flow (dilution-adjusted): -22000000
Buyback yield (%): 0
Retained earnings: -848000000
Inventory turnover: 0.6748366013071896
Receivables turnover: 1.455298013245033
Capitalized R&D asset: 36000000
ROCI (R&D-adjusted, %): 2.1896109946424414
FCF margin (%): -2.502844141069397
Rule of 40 score: -2.502844141069397
Financial ratios for XRAY — quarterly report dated 2025-06-30
Total revenue: 936000000
Gross profit: 490000000
Operating income: 110000000
Net income: -44000000
Capital expenditures: 0
Operating cash flow: 48000000
Depreciation & amortization: 88000000
Net tangible assets: -701000000
Owner earnings: 44000000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.45
Shares outstanding: 200326683
Book value: 1961000000
P/B ratio: 1.5783004856450789
Market cap (USD): 3095047252.35
Debt to equity: 1.2718001019887812
Current ratio: 1.686106346483705
Quick ratio: 1.1072041166380788
Interest coverage ratio: 4.583333333333333
COGS to revenue (%): 47.64957264957265
R&D to revenue (%): 3.9529914529914527
SG&A to revenue (%): 36.64529914529914
Free cash flow (dilution-adjusted): 7000000
Buyback yield (%): 0
Retained earnings: -925000000
Inventory turnover: 0.6607407407407407
Receivables turnover: 1.4489164086687307
Capitalized R&D asset: 61120000
ROCI (R&D-adjusted, %): 2.4710657008022907
Rosenberg metric: 0.6666666666666666
FCF margin (%): 0.7478632478632479
Revenue growth (%): 6.484641638225256
Rule of 40 score: 7.2325048860885035
Financial ratios for XRAY — quarterly report dated 2025-09-30
Total revenue: 904000000
Gross profit: 441000000
Operating income: 46000000
Net income: -427000000
Capital expenditures: 39000000
Operating cash flow: 79000000
Depreciation & amortization: 92000000
Net tangible assets: -857000000
Owner earnings: -374000000
Capex to operating income (%): 84.78260869565217
Buffett classification: The Gruesome
Stock price: 12.51
Shares outstanding: 200326683
Book value: 1478000000
P/B ratio: 1.69559323702977
Market cap (USD): 2506086804.33
Debt to equity: 1.6779431664411366
Current ratio: 1.4747330960854093
Quick ratio: 0.9864768683274021
Interest coverage ratio: 2
COGS to revenue (%): 51.216814159292035
R&D to revenue (%): 4.092920353982301
SG&A to revenue (%): 39.60176991150443
Free cash flow (dilution-adjusted): 34000000
Buyback yield (%): 0
Retained earnings: -1385000000
Inventory turnover: 0.6749271137026239
Receivables turnover: 1.382262996941896
Capitalized R&D asset: 73670000
ROCI (R&D-adjusted, %): 1.0721164117883442
Rosenberg metric: -1.3243243243243243
FCF margin (%): 3.761061946902655
Revenue growth (%): -3.418803418803419
Rule of 40 score: 0.34225852809923607
Financial ratios for XRAY — quarterly report dated 2025-12-31
Total revenue: 961000000
Gross profit: 443000000
Operating income: 25000000
Net income: -145000000
Capital expenditures: 41000000
Operating cash flow: 101000000
Depreciation & amortization: 93000000
Net tangible assets: -783000000
Owner earnings: -93000000
Capex to operating income (%): 164
Buffett classification: The Gruesome
Stock price: 11.43
Shares outstanding: 200326683
Book value: 1340000000
P/B ratio: 1.7087567064850746
Market cap (USD): 2289733986.69
Debt to equity: 1.8417910447761194
Current ratio: 1.5063291139240507
Quick ratio: 1.028294862248697
Interest coverage ratio: 1.1363636363636365
COGS to revenue (%): 53.90218522372528
R&D to revenue (%): 4.162330905306972
SG&A to revenue (%): 39.334027055150884
Free cash flow (dilution-adjusted): 52000000
Buyback yield (%): 0
Retained earnings: -1564000000
Inventory turnover: 0.8068535825545171
Receivables turnover: 1.3039348710990502
Capitalized R&D asset: 77000000
ROCI (R&D-adjusted, %): 0.6485707422531828
Rosenberg metric: 0.05405405405405406
FCF margin (%): 5.411030176899064
Revenue growth (%): 6.3053097345132745
Rule of 40 score: 11.716339911412337
Financial ratios for XRAY — annual report dated 2025-12-31
Total revenue: 3680000000
Gross profit: 1840000000
Operating income: 252000000
Net income: -598000000
Capital expenditures: 131000000
Operating cash flow: 235000000
Depreciation & amortization: 352000000
Net tangible assets: -783000000
Owner earnings: -377000000
Capex to operating income (%): 51.98412698412699
Buffett classification: The Good
Stock price: 11.43
Shares outstanding: 200326683
Book value: 1340000000
P/B ratio: 1.7087567064850746
Market cap (USD): 2289733986.69
Debt to equity: 1.8417910447761194
Current ratio: 1.5063291139240507
Quick ratio: 1.028294862248697
Interest coverage ratio: 2.8636363636363638
COGS to revenue (%): 50
R&D to revenue (%): 4.076086956521739
SG&A to revenue (%): 39.076086956521735
Free cash flow (dilution-adjusted): 71000000
Buyback yield (%): 0
Retained earnings: -1564000000
Inventory turnover: 2.866043613707165
Receivables turnover: 4.993215739484397
Capitalized R&D asset: 321270000
ROCI (R&D-adjusted, %): 5.347225531148912
Rosenberg metric: -0.7151515151515152
FCF margin (%): 1.9293478260869565
Revenue growth (%): -2.9791721592407066
Rule of 40 score: -1.04982433315375
Financial ratios for 146A.T — annual report dated 2022-12-31
Total revenue: 82854348.48028891
Gross profit: 24751730.364128802
Operating income: 16476075.835088776
Net income: 8832380.379175445
Capital expenditures: 2114053.56605477
Operating cash flow: -43183869.99699067
Depreciation & amortization: 1188684.9232621128
Net tangible assets: 42897983.749623835
Owner earnings: 7907011.736382789
Return on net tangible assets (%): 18.432129077516667
Capex to operating income (%): 12.8310502283105
Buffett classification: The Great
Shares outstanding: 7668600
Book value: 43620222.69034007
Debt to equity: 3.390134529147981
Current ratio: 3.1738400488400487
Quick ratio: 0.5462454212454209
Effective tax rate (%): 35.11871893981226
Interest coverage ratio: 9.90950226244344
COGS to revenue (%): 70.1171342958322
Free cash flow (dilution-adjusted): -46110442.37135119
Retained earnings: 42822750.52663256
Inventory turnover: 0.44853624535315983
Receivables turnover: 579.6315789473684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.71900543292056
FCF margin (%): -55.652410787251426
Rule of 40 score: -55.652410787251426
Financial ratios for 146A.T — annual report dated 2023-12-31
Total revenue: 102305027.22194725
Gross profit: 27229017.888708193
Operating income: 19225058.332744114
Net income: 10719083.64561974
Capital expenditures: 8032242.09856466
Operating cash flow: -12571590.185957717
Depreciation & amortization: 1555539.8430318886
Net tangible assets: 49840910.69787174
Owner earnings: 4242381.390086969
Return on net tangible assets (%): 8.511845651865514
Capex to operating income (%): 41.78006620080912
Buffett classification: The Good
Shares outstanding: 7668600
Book value: 50484338.542034954
Debt to equity: 3.258263305322127
Current ratio: 2.460567470956211
Quick ratio: 0.45732797140303855
Effective tax rate (%): 33.289357959542656
Interest coverage ratio: 9.34364261168385
COGS to revenue (%): 73.37756583039601
Free cash flow (dilution-adjusted): -20610902.920172524
Retained earnings: 49734851.16311956
Inventory turnover: 0.5920370267105336
Receivables turnover: 371
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.796607228079308
FCF margin (%): -20.146520146520146
Revenue growth (%): 23.475748827215355
Rule of 40 score: 3.329228680695209
Financial ratios for 158A.T — annual report dated 2021-12-31
Total revenue: 14326820.789153485
Gross profit: 6094863.549452459
Operating income: 553398.2270119938
Net income: 529358.5955153833
Capital expenditures: 3441.682600382409
Operating cash flow: 852563.8797149314
Depreciation & amortization: 18807.578654614983
Net tangible assets: 1456414.044846167
Owner earnings: 544724.4915696159
Return on net tangible assets (%): 37.40176040578846
Capex to operating income (%): 0.6219178942739578
Buffett classification: The Great
Shares outstanding: 172000
Book value: 1495167.73857118
Debt to equity: 1.1585674924724183
Current ratio: 1.8687508337255516
Quick ratio: 1.491521797675888
Effective tax rate (%): 36.8580373618627
Interest coverage ratio: 93.22693997071742
COGS to revenue (%): 57.458366799236124
SG&A to revenue (%): 38.67896028011871
Free cash flow (dilution-adjusted): 837389.1882496089
Retained earnings: 973700.6779071789
Inventory turnover: 6.319599941285579
Receivables turnover: 17.308497569273094
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.096996912980185
FCF margin (%): 5.844905862740863
Rule of 40 score: 5.844905862740863
Financial ratios for 158A.T — annual report dated 2022-12-31
Total revenue: 13057658.742100513
Gross profit: 6004476.376767981
Operating income: 166784.532049353
Net income: 61149.563647306655
Capital expenditures: 6357.207342762565
Operating cash flow: 113083.05747818238
Depreciation & amortization: 19124.285284381585
Net tangible assets: 1288963.2861871803
Owner earnings: 73916.64158892568
Return on net tangible assets (%): 5.7345808357020704
Capex to operating income (%): 3.811628851098381
Buffett classification: The Great
Shares outstanding: 172000
Book value: 1323066.5061691245
Debt to equity: 0.4715629300246784
Current ratio: 2.1167223655054666
Quick ratio: 1.5920060057878356
Effective tax rate (%): 83.8688550618215
Interest coverage ratio: 51.198614318706696
COGS to revenue (%): 54.015616285554934
SG&A to revenue (%): 44.707033320580955
Free cash flow (dilution-adjusted): 91852.24195004515
Retained earnings: 871667.1682214867
Inventory turnover: 5.408523182895944
Receivables turnover: 14.110075931255386
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.124086140305056
FCF margin (%): 0.7034357671938162
Revenue growth (%): -8.85864397783091
Rule of 40 score: -8.155208210637094
Financial ratios for 158A.T — annual report dated 2023-12-31
Total revenue: 13247210.634236017
Gross profit: 6633635.013787739
Operating income: 215109.94838435974
Net income: 192328.36031959273
Capital expenditures: 178667.89224351267
Operating cash flow: 532871.3851375239
Depreciation & amortization: 31379.481015343277
Net tangible assets: 1379070.9184755709
Owner earnings: 45039.94909142333
Return on net tangible assets (%): 3.2659632284328515
Capex to operating income (%): 83.05886993393156
Buffett classification: The Gruesome
Shares outstanding: 172000
Book value: 1405380.7537297597
Debt to equity: 0.6792008573024158
Current ratio: 2.5732966916255116
Quick ratio: 2.192524958844459
Effective tax rate (%): 41.48183206763763
Interest coverage ratio: 57.51039697542533
COGS to revenue (%): 49.92428823737573
SG&A to revenue (%): 48.45189861188875
Free cash flow (dilution-adjusted): 347557.0953828749
Retained earnings: 981142.6147210634
Inventory turnover: 8.15304423621704
Receivables turnover: 14.077021330949036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.458371907765841
FCF margin (%): 2.6236247386649856
Revenue growth (%): 1.4516529791389883
Rule of 40 score: 4.075277717803974
Financial ratios for 305A.T — annual report dated 2022-12-31
Total revenue: 94328287.69184473
Gross profit: 24249954.86006621
Operating income: 3387910.0210653027
Net income: 3056755.9434246165
Capital expenditures: 2110427.3247065907
Operating cash flow: 6597923.563045441
Depreciation & amortization: 1857816.7318687935
Net tangible assets: 24934065.60337045
Owner earnings: 2804145.3505868195
Return on net tangible assets (%): 11.246241969491612
Capex to operating income (%): 62.2928977329505
Buffett classification: The Good
Shares outstanding: 3000000
Book value: 26035953.95726753
Debt to equity: 0.5911516719599134
Current ratio: 1.959227167005856
Quick ratio: 1.2054315321676288
Effective tax rate (%): 12.973708165997323
Interest coverage ratio: 67.24219799910408
COGS to revenue (%): 74.29195103953418
Free cash flow (dilution-adjusted): 4367062.894974421
Retained earnings: 25659878.122178756
Inventory turnover: 6.415463957998004
Receivables turnover: 52.464029123166725
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.862805329873662
FCF margin (%): 4.629642922429493
Rule of 40 score: 4.629642922429493
Financial ratios for 305A.T — annual report dated 2023-12-31
Total revenue: 108719479.60121614
Gross profit: 25332355.228735063
Operating income: 5405104.998939404
Net income: 3933741.0733224917
Capital expenditures: 942105.6352966131
Operating cash flow: 4270458.884253694
Depreciation & amortization: 1652110.5847415682
Net tangible assets: 26901711.093827333
Owner earnings: 4643746.022767447
Return on net tangible assets (%): 17.26189834754774
Capex to operating income (%): 17.42992292437379
Buffett classification: The Great
Shares outstanding: 3000000
Book value: 27858799.406066608
Debt to equity: 0.518544086780184
Current ratio: 2.1980484679609082
Quick ratio: 1.3937208261722922
Effective tax rate (%): 30.56296085508744
Interest coverage ratio: 90.48816287878788
COGS to revenue (%): 76.6993474849046
Free cash flow (dilution-adjusted): 3287223.361380188
Retained earnings: 27505203.987838507
Inventory turnover: 7.45552613129402
Receivables turnover: 57.84547899855162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.80617669841507
FCF margin (%): 3.023582685860664
Revenue growth (%): 15.256496499104388
Rule of 40 score: 18.280079184965054